Company: PTPI
Filing Date: 2025-02-10
Form Type: S-1/A
Source: 0001410578-25-000108
Chunk: 193

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-10
Form: S-1/A
Chunk 193
---
 blocker), and (ii) 107.69 shares of Series A Preferred Stock, convertible into up to approximately 47,862 shares of common stock within 60 days of February 6, 2025 (subject to a 4.99% beneficial ownership blocker). |

The business address of 3i, LP is 2 Wooster St. Fl 2, New York, NY 10013. 3i, LP’s principal business is that of a private investor. Maier Joshua Tarlow is the manager of 3i Management, LLC, the general partner of 3i, LP, and has sole voting control and investment discretion over securities beneficially owned directly by 3i, LP and indirectly by 3i Management, LLC.

| (7) | Amount consists of (1) 13,347 shares of common stock and (2) 84,000 shares of common stock underlying stock options held by Mr. Bernstein that were vested as of February 6, 2025 or will vest within 60 days thereafter. |

| (8) | Amount consists of (1) 16,238 shares of common stock and (2) 84,000 shares of common stock underlying stock options held by Mr. Silverman that were vested as of February 6, 2025 or will vest within 60 days thereafter. |

| (9) | Amount consists of (1) 13,315 shares of common stock and (2) 84,000 shares of common stock underlying stock options held by Mr. Walker that were vested as of February 6, 2025 or will vest within 60 days thereafter. |

| (10) | Amount consists of (i) 76,100 shares of common stock underlying stock options held by Mr. Boctor that were vested as of February 6, 2025 or will vest within 60 days thereafter and (ii) 49,645 shares of common stock underlying certain restricted stock units that were vested as of February 6, 2025 or will vest within 60 days thereafter. |

| (11) | Amount consists of (1) 117 shares of common stock held directly and (2) 25,000 shares of common stock underlying stock options held by Mr. Arnold that were vested as of February 6, 2025 or will vest within 60 days thereafter. |

113

<div align='center'>EXPERTS</div>

The consolidated financial statements of Petros Pharmaceuticals, Inc. as